找回密碼
 To register

QQ登錄

只需一步，快速開始

掃一掃，訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Drug Targets in Cellular Processes of Cancer: From Nonclinical to Preclinical Models; Hardeep Singh Tuli Book 2020 The Editor(s) (if appli

[復制鏈接]
查看: 22913|回復: 47
樓主
發(fā)表于 2025-3-21 17:56:02 | 只看該作者 |倒序瀏覽 |閱讀模式
書目名稱Drug Targets in Cellular Processes of Cancer: From Nonclinical to Preclinical Models
編輯Hardeep Singh Tuli
視頻videohttp://file.papertrans.cn/284/283132/283132.mp4
概述Explores various cellular targets for cancer therapy.Reviews the role of inflammatory molecules and reactive oxygen species as potential targets for drug development.Examines the potential of apoptoti
圖書封面Titlebook: Drug Targets in Cellular Processes of Cancer: From Nonclinical to Preclinical Models; Hardeep Singh Tuli Book 2020 The Editor(s) (if appli
描述.This book explores potential cellular drug targets for cancer therapy. The first couple of chapters describe conventional treatment (radiotherapy, chemotherapy, and immunotherapy) & detection (biosensors) strategies for cancer. In contrast, the subsequent chapters address the role of cyclin-dependent kinases and cell cycle regulatory proteins in the growth of cancer cells and their potential as target for cancer treatment. The book then discusses the regulation of various pro-apoptotic and anti-apoptotic proteins via chemotherapeutic drugs. In addition, it examines the molecular mechanisms that are critical for mediating autophagic cell death in cancer cells. It subsequently reviews the role of reactive oxygen (ROS) species during carcinogenesis and during chemotherapy, and the potential of anti-inflammatory routes for the development of new therapeutic modulators. Lastly, it describes therapeutic strategies that target the tumor microenvironment and various angiogenic pathways forthe treatment of cancer and to develop personalized medicine. ?Given its scope, the book is valuable resource for oncologists, cancer researchers, clinicians, and pharmaceutical industry personnel..
出版日期Book 2020
關鍵詞Cancer; Drug targets; Apoptosis; Cell-cycle regulators; Autophagy; Angiogenesis oxidation
版次1
doihttps://doi.org/10.1007/978-981-15-7586-0
isbn_softcover978-981-15-7588-4
isbn_ebook978-981-15-7586-0
copyrightThe Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Singapor
The information of publication is updating

書目名稱Drug Targets in Cellular Processes of Cancer: From Nonclinical to Preclinical Models影響因子(影響力)




書目名稱Drug Targets in Cellular Processes of Cancer: From Nonclinical to Preclinical Models影響因子(影響力)學科排名




書目名稱Drug Targets in Cellular Processes of Cancer: From Nonclinical to Preclinical Models網絡公開度




書目名稱Drug Targets in Cellular Processes of Cancer: From Nonclinical to Preclinical Models網絡公開度學科排名




書目名稱Drug Targets in Cellular Processes of Cancer: From Nonclinical to Preclinical Models被引頻次




書目名稱Drug Targets in Cellular Processes of Cancer: From Nonclinical to Preclinical Models被引頻次學科排名




書目名稱Drug Targets in Cellular Processes of Cancer: From Nonclinical to Preclinical Models年度引用




書目名稱Drug Targets in Cellular Processes of Cancer: From Nonclinical to Preclinical Models年度引用學科排名




書目名稱Drug Targets in Cellular Processes of Cancer: From Nonclinical to Preclinical Models讀者反饋




書目名稱Drug Targets in Cellular Processes of Cancer: From Nonclinical to Preclinical Models讀者反饋學科排名




單選投票, 共有 0 人參與投票
 

0票 0%

Perfect with Aesthetics
 

0票 0%

Better Implies Difficulty
 

0票 0%

Good and Satisfactory
 

0票 0%

Adverse Performance
 

0票 0%

Disdainful Garbage
您所在的用戶組沒有投票權限
沙發(fā)
發(fā)表于 2025-3-21 22:05:46 | 只看該作者
板凳
發(fā)表于 2025-3-22 00:32:37 | 只看該作者
地板
發(fā)表于 2025-3-22 05:34:31 | 只看該作者
5#
發(fā)表于 2025-3-22 11:07:30 | 只看該作者
Regulatory Roles of Autophagy in Cancer,sses, including organelle damage, deprivation of nutrients, and accumulation of damaged proteins lead to autophagy that can be associated with cell survival or cell death. Autophagy is initiated with the formation of autophagosome which is a double membrane vesicle. Autophagosome fuses with the lyso
6#
發(fā)表于 2025-3-22 14:16:23 | 只看該作者
ROS and Oxidative Stress in Cancer: Recent Advances,des. The sensitive redox balance that is controlled through an improved antioxidant system along with the enzymatic and non-enzymatic ROS production pathways sustains physiological functions in the healthy cells. During the course of cancer, a progressive deterioration of the redox balance can be fo
7#
發(fā)表于 2025-3-22 18:47:41 | 只看該作者
Inflammatory Mediators: Potential Drug Targets in Cancer,neration and cancer. Previously it has been seen that inflammatory markers such as cytokines and chemokines are elevated several times in cancer patients. Majorly, NF-kβ is one among the other inflammation-inducing pathways, which have been found to be inhibited by various chemotherapeutic drugs. Th
8#
發(fā)表于 2025-3-22 22:17:16 | 只看該作者
9#
發(fā)表于 2025-3-23 04:23:17 | 只看該作者
Metastasis: A Major Driver of Cancer Pathogenesis,gulations and proliferate incessantly. Furthermore, the accumulation of these mutations confers metastatic abilities to the tumor cells, which help them in contriving various features essential for invasion of the host tissues and evading immune surveillance and thus spreading to distant sites. Meta
10#
發(fā)表于 2025-3-23 09:22:41 | 只看該作者
Designing Personalized and Innovative Novel Drug Therapies for Cancer Treatment,ted molecular therapy approach have not been effective in complete eradication of all tumor cells and is often been limited by drug resistance and side effects on normal tissues and cells. With the fast evolving field of genomics and molecular medicine translating into precision medicine, the import
 關于派博傳思  派博傳思旗下網站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網 吾愛論文網 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經驗總結 SCIENCEGARD IMPACTFACTOR 派博系數 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網安備110108008328) GMT+8, 2025-10-12 20:53
Copyright © 2001-2015 派博傳思   京公網安備110108008328 版權所有 All rights reserved
快速回復 返回頂部 返回列表
建湖县| 汉川市| 铜山县| 宝山区| 望谟县| 靖边县| 正阳县| 黔东| 大丰市| 香河县| 余姚市| 克拉玛依市| 城步| 英吉沙县| 祁东县| 毕节市| 崇信县| 沅江市| 乌拉特中旗| 定远县| 区。| 鄢陵县| 容城县| 淳化县| 唐河县| 永寿县| 嘉义市| 大丰市| 青田县| 五指山市| 汝南县| 万山特区| 仙游县| 仪陇县| 宾川县| 贵州省| 保康县| 房山区| 广平县| 新田县| 互助|